APA

Milton D. T., Azzoli C. G., Heelan R. T., Venkatraman E., Gomez J. E., Kris M. G., Krug L. M., Pao W., Rizvi N. A., Dunne M. & Miller V. A. (20061002). A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer. : Cancer.

Chicago

Milton Daniel T, Azzoli Christopher G, Heelan Robert T, Venkatraman Ennapadam, Gomez Jorge E, Kris Mark G, Krug Lee M, Pao William, Rizvi Naiyer A, Dunne Megan and Miller Vincent A. 20061002. A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer. : Cancer.

Harvard

Milton D. T., Azzoli C. G., Heelan R. T., Venkatraman E., Gomez J. E., Kris M. G., Krug L. M., Pao W., Rizvi N. A., Dunne M. and Miller V. A. (20061002). A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer. : Cancer.

MLA

Milton Daniel T, Azzoli Christopher G, Heelan Robert T, Venkatraman Ennapadam, Gomez Jorge E, Kris Mark G, Krug Lee M, Pao William, Rizvi Naiyer A, Dunne Megan and Miller Vincent A. A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer. : Cancer. 20061002.